Xuantai Pharmaceutical disclosed its semi-annual report on August 27. The company achieved operating income of 191 million yuan in the first half of the year, a year-on-year decrease of 12.95%; net profit attributable to shareholders of listed companies was 29.7018 million yuan, a year-on-year decrease of 34.84%; and basic earnings per share were 0.07 yuan/share. The company plans to distribute a cash dividend of 0.15 yuan for every 10 shares to all shareholders.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.